£120.81

Springer Malignant Lymphomas and Hodgkin's Disease Volume 66

Price data last checked 54 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 37 days • 37 data points (No recent data available)

Historical
Generating forecast...
£125.55 £120.34 £121.47 £122.61 £123.75 £124.89 £126.02 28 January 2026 06 February 2026 15 February 2026 24 February 2026 05 March 2026

Price Distribution

Price distribution over 37 days • 2 price levels

Days at Price
Current Price
1 day · current 36 days 0 9 18 27 36 £121 £126 Days at Price

Price Analysis

Most common price: £126 (36 days, 97.3%)

Price range: £121 - £126

Price levels: 2 different prices over 37 days

Description

Stay updated with the latest advancements in oncology with this specialized volume from the Cancer Treatment and Research series. Published by Springer, this book provides a wide selection of informative reviews focusing on malignant lymphomas, including Hodgkin's disease. As the understanding of lymphomagenesis grows, medical professionals need access to precise morphologic classification and new therapeutic insights. This text addresses the rapid expansion of knowledge in the field, covering the arrival of new cytotoxic and biologic therapeutic agents. It also examines modern drug delivery strategies that are changing how these diseases are treated. This volume is designed to help readers navigate the shift from old standard approaches to modern clinical practices. It serves as a comprehensive resource for those tracking the explosive growth of insight into the basic mechanisms of these diseases. Whether you are looking for updates on new drug developments or more accurate classification methods, this publication offers the detailed reviews necessary for modern medical practice.

Key Features

Comprehensive reviews on malignant lymphomas and Hodgkin's disease to assist in clinical understanding.

Updates on the rapid growth of insight regarding the basic mechanisms of lymphomagenesis.

Detailed information on new therapeutic agents, including both cytotoxic and biologic options.

Coverage of emerging drug delivery strategies to assist in modern treatment planning.

Focus on the need for precise morphologic classification in diagnosing these diseases.

Expert analysis of how new developments are changing traditional standard approaches.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 July 1993
Listed Since
09 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)
99% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)

Springer

£113.11 07 Jan 2026
Controversies in the Management of Lymphomas: Including Hodgkin’s disease: 16 (Cancer Treatment and Research, 16)
94% match

Controversies in the Management of Lymphomas: Including Hodgkin’s disease: 16 (Cancer Treatment and Research, 16)

Springer

£85.30 08 Mar 2026
Aggressive Lymphomas (Hematologic Malignancies)
94% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£88.97 08 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
94% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 09 Mar 2026
Rare Lymphomas (Hematologic Malignancies)
94% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£109.04 19 Dec 2025
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
94% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£244.99 14 Jan 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
94% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£291.99 11 Jan 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
94% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
94% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£69.58 07 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
93% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 09 Mar 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
93% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£77.39 11 Mar 2026
Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)
93% match

Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)

Springer

£165.83 12 Apr 2026
Clinical Malignant Hematology
93% match

Clinical Malignant Hematology

McGraw-Hill Education

£103.37 14 Jan 2026
The Peripheral T-Cell Lymphomas
93% match

The Peripheral T-Cell Lymphomas

Wiley-Blackwell

£100.90 13 Jan 2026
Atlas of Hematologic Neoplasms
93% match

Atlas of Hematologic Neoplasms

Springer

£180.00 12 Jan 2026
Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book
93% match

Springer Hodgkin's and Non-Hodgkin's Lymphoma - Research Book

Springer

£44.30 04 Apr 2026
Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias: 38 (Cancer Treatment and Research, 38)
93% match

Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias: 38 (Cancer Treatment and Research, 38)

Springer

£148.82 10 Mar 2026
Follicular Lymphoma and Mantle Cell Lymphoma: Pathobiology, Diagnosis and Treatment (Molecular and Translational Medicine)
93% match

Follicular Lymphoma and Mantle Cell Lymphoma: Pathobiology, Diagnosis and Treatment (Molecular and Translational Medicine)

Humana

£77.74 10 Mar 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
93% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.36 01 Mar 2026
Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)
93% match

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Springer

£149.65 14 Apr 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
93% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£150.48 10 Mar 2026
Consulting Hematology and Oncology Handbook
93% match

Consulting Hematology and Oncology Handbook

Springer

£57.66 08 Mar 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
93% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£65.04 28 Feb 2026
T-Cell Lymphomas (Contemporary Hematology)
93% match

T-Cell Lymphomas (Contemporary Hematology)

Humana

£79.93 23 Feb 2026